📰 Punit Patel News
Punit Patel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Punit Patel. Real-time updates on events, politics, business and more.
April 23, 2024
According to IQVIA MAT data, Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion in the United States.
April 22, 2024
The company has launched Mirabegron extended-release tablets in strength of 25 mg in the US market after having received final approval from the US Food and Drug Administration (USFDA), Zydus Lifesciences said in a regulatory filing.
April 22, 2024
Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United States Food and Drug...
October 20, 2023
The approval was announced by Zydus Life Sciences Limited in a press release on October 20, 2023.
October 16, 2023
Punit Patel will be based out of the groups office in Pennington, New Jersey, US, it added. Before joining Zydus, he was the President of Red Oak Sourcing, leading the companys
October 16, 2023
Before joining Zydus, he was the President of Red Oak Sourcing, leading the companys "multibillion-dollar generic portfolio", overseeing all aspects of Red Oaks business. Patel, who has more than 20 years of experience in the generics and branded pharmaceutical marketplace, has also worked at Novartis Vaccines & Diagnostics and CVS Caremark, Zydus said.
October 16, 2023
Patel said that he looks forward to joining Zydus and creating new avenues for growth
October 16, 2023
Zydus Lifesciences Limited announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas. He will be responsible for the business operations of all Zydus entities in...
April 14, 2022
AN EXPERIENCED postmaster has officially opened a brand new Post Office branch in Andover.
February 15, 2022
Australian shares are set to advance after Wall Street surged, buoyed by signs of an apparent easing in the Russia-Ukraine conflict.